Contrast-Induced Nephropathy:
Addressing the Needs of the High-Risk Patient

Faculty

Peter A. McCullough, MD, MPH, FACC, FACP, FCCP, FAHA (Chairman) Consultant Cardiologist and Chief of Preventive Medicine William Beaumont Hospital Royal Oak, Michigan	Charles Joseph Davidson, MD, FACC, FSCAI, FAHA Professor of Medicine Director, Interventional Cardiology Training Program Northwestern University Medical School Chief, Cardiac Catheterization Laboratory Northwestern Memorial Hospital Chicago, Illinois
Roxana Mehran, MD, FACC, FAHA Director of Clinical Research and Data Coordinating Center Cardiovascular Research Foundation Lenox Hill Heart and Vascular Institute New York, New York	James A. Tumlin, MD Associate Professor of Medicine Renal Division, Department of Internal Medicine Emory University Atlanta, Georgia
Norman E. Lepor, MD, FACC, FAHA Associate Clinical Professor of Medicine David Geffen School of Medicine at UCLA Attending Cardiologist at Cedars-Sinai Medical Center Los Angeles, California

This event was not part of the official ACC Annual Scientific Session as planned by the Annual Scientific Session Program Committee (ASSPC)

Topics Featured

• Causes and Consequences of Contrast-Induced Nephropathy and Other Major Adverse Coronary Events
  Peter A. McCullough, MD, MPH
• Evidence-Based Risk Stratification for Contrast-Induced Nephropathy
  Roxana Mehran, MD
• Comprehensive Prevention Strategies for High-Risk Patients Receiving Iodinated Contrast
  Norman E. Lepor, MD
• Clinical Effectiveness of a Hospital-Wide Renal Protection Program for Patients Undergoing Contrast Procedures
  James A. Tumlin, MD
• A Future Look at Imaging the High-Risk Patient with Systemic Vascular Disease and Other Major Adverse Clinical Events
  Charles J. Davidson, MD

Program Objectives

• Understand the causes and consequences of contrast-induced nephropathy in your high-risk patients
• Review the evidence for renal prevention strategies
• Discuss the rationale and evidence for the use of iso-osmolar contrast agents in patients at high risk for developing radiocontrast nephropathy and major adverse clinical effects
• Understand the impact of a hospital-wide renal prevention strategy in high-risk patients
• Highlight future directions in renal protection for the cardiovascular patient

Target Audience
Cardiologists, nephrologists, and other healthcare professionals who treat patients at risk for developing radiocontrast nephropathy and other major adverse coronary events.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of SUNY Downstate Medical Center and MedReviews®, LLC. SUNY Downstate is accredited by the ACCME to provide continuing medical education to physicians.

SUNY Downstate designates this educational activity for a maximum of 2 category 1 credit(s) toward the American Medical Association Physician's Recognition Award (AMA PRA). Each physician should claim only those hours of credit that he/she actually spent in the activity.

Disclaimer
SUNY Downstate Medical Center and its affiliates are committed to providing educational activities that are objective, balanced, and as free of bias as possible. All participating faculty are expected to disclose to the audience, verbally or in writing, any commercial relationships that might be perceived as a real or apparent conflict of interest related to the content of their presentations, i.e., with companies whose products or services are related to the subject matter of the presentation; or products in the research and development phase.

Supported by an unrestricted educational grant from:

Sponsored by:

Coordinated by: